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Abstract
Background: Direct conversion of solar energy and carbon dioxide to drop in fuel molecules in a single biological
system can be achieved from fatty acid-based biofuels such as fatty alcohols and alkanes. These molecules have
similar properties to fossil fuels but can be produced by photosynthetic cyanobacteria.
Results: Synechocystis sp. PCC6803 mutant strains containing either overexpression or deletion of the slr1609 gene,
which encodes an acyl-ACP synthetase (AAS), have been constructed. The complete segregation and deletion in all
mutant strains was confirmed by PCR analysis. Blocking fatty acid activation by deleting slr1609 gene in wild-type
Synechocystis sp. PCC6803 led to a doubling of the amount of free fatty acids and a decrease of alkane production
by up to 90 percent. Overexpression of slr1609 gene in the wild-type Synechocystis sp. PCC6803 had no effect on
the production of either free fatty acids or alkanes. Overexpression or deletion of slr1609 gene in the Synechocystis
sp. PCC6803 mutant strain with the capability of making fatty alcohols by genetically introducing fatty acyl-CoA
reductase respectively enhanced or reduced fatty alcohol production by 60 percent.
Conclusions: Fatty acid activation functionalized by the slr1609 gene is metabolically crucial for biosynthesis of
fatty acid derivatives in Synechocystis sp. PCC6803. It is necessary but not sufficient for efficient production of
alkanes. Fatty alcohol production can be significantly improved by the overexpression of slr1609 gene.
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Background
Biofuel production from renewable sources is considered
as a feasible solution to the energy and environmental
problems we are facing. It is very important to explore
and develop advanced biofuels alongside traditional bio-
fuels such as bioethanol and biodiesel to ensure sufficient
supply of renewable energy at a time when demand for
energy is set to increase over the coming decades.
Advanced biofuels possess higher energy density, hydro-
phobic properties and compatibility with existing liquid
fuel infrastructure including fuel engines, refinery equip-
ment and transportation/distribution pipelines, whilst
serving as better alternatives to fuels produced from fossil
fuels [1].
In terms of fuel properties the best replacement of
petroleum fuels is “Petroleum Fuels”. This means ideal
biofuels produced from biological systems should be
chemically similar to petroleum, such as fatty acid-based
molecules including fatty alcohols and fatty alkanes [2].
As a candidate for biofuel-producing microbial systems,
cyanobacteria have become more and more attractive due
to their specific characteristics as photosynthetic bacteria.
Compared to generally utilized biofuel-producing
microbes such as E. coli and S.cerevisiae, cyanobacteria are
photosynthetic microbes, which can convert solar energy
and carbon dioxide more efficiently into biofuels in one
biological system. In contrast to plants and eukaryotic
algae, cyanobacteria are prokaryotic microbes with the
ability to grow a lot faster. Genetic engineering platforms
for cyanobacteria are well established and they are highly
tolerable to heterogeneous genes. So far over 40 genomic
sequences of cyanobacteria strains are available, therefore
* Correspondence: lvxf@qibebt.ac.cn
1Key Laboratory of Biofuels, Qingdao Institute of Bioenergy and Bioprocess
Technology, Chinese Academy of Sciences, No. 189 Songling Road, Qingdao
266101, China
Full list of author information is available at the end of the article
Gao et al. Biotechnology for Biofuels 2012, 5:17
http://www.biotechnologyforbiofuels.com/content/5/1/17
© 2012 Gao et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
genetic information on cyanobacteria are relatively robust
http://genome.kazusa.or.jp/cyanobase. This makes genetic
engineering toward efficiently producing biofuels in cyano-
bacteria to be a more realistic and feasible option [3-5].
Recently, the alkane biosynthetic pathway was identified
in cyanobacteria with two enzyme families including an
acyl carrier protein (ACP) reductase (AAR) and an alde-
hyde decarbonylase (ADC) [6]. Genes associated with an
alcohol-forming fatty acyl-CoA reductase (FAR) have not
been reported in cyanobacteria, C16:0 and C18:0 alcohols
can be produced by engineered cyanobacteria containing
the FAR gene derived from jojoba [7] or Arabidopsis thali-
ana [4]. The overall pathway of the fatty acid, fatty alcohol
and fatty alkane in wild-type or engineered Synechocystis
strains were illustrated in Figure 1.
The fatty acid molecules must be activated to fatty
acyl-thioesters by fatty acyl-CoA synthetase (ACS, EC
6.2.1.3) or fatty acyl-ACP synthetase (AAS, EC 6.2.1.20)
prior to the synthesis of fatty alcohols and alkanes.
Based on sequence identity analysis, Synechocystis sp.
PCC 6803 encodes only a single candidate gene for fatty
acid activation, annotated as AAS and designated as
slr1609 [8]. The slr1609-deletion cyanobacteria mutant
was incapable of utilizing exogenous fatty acids and thus
secreted endogenous fatty acids into the medium. The
detected free fatty acids are released from membrane
lipids. The data suggest a remarkable turnover of lipids
and a role of AAS activity in recycling the released fatty
acids [8].
The overall pathway of the fatty acid, fatty alcohol and
alkane in wild-type or engineered Synechocystis strains
are illustrated in Figure 1. Synechocystis sp. PCC6803
mutant strains with either overexpression or deletion of
slr1609 gene have been constructed in this study. The
results indicated that the AAS gene was metabolically
crucial for production of free fatty acids and fatty acid
derivatives in Synechocystis sp. PCC6803.
Results and discussion
Construction of Synechocystis sp. PCC6803 mutants
with either overexpression or deletion of slr1609
gene
To investigate the impact of AAS on production of free
fatty acids and fatty acid derivatives, we constructed two
plasmids pGQ11 (Figure 2B) and pGQ49 (Figure 2D) for
over-expressing slr1609 gene, driven by a strong constitu-
tive promoter Prbc or PpsbA2 and integrated into slr0168
[9] or psbA2 site, respectively. Two plasmids pGQ53
(Figure 2A) and pGQ17 (Figure 2C) were constructed for
disruption of slr1609 gene with erythromycin or kanamy-
cin resistance cassettes, respectively. The plasmid pGQ11
or pGQ53 was transformed into Synechocystis sp.
PCC6803 generating GQ3 and GQ8 strains respectively
for analysis of fatty acid and alkane production. The plas-
mid pGQ49 or pGQ17 was transformed into fatty-alco-
hol-producing strain Syn-XT14 generating GQ5 and GQ6
respectively for analysis of fatty alcohol production. Over-
expressed AAS protein with C-terminal His-tag in GQ3
and GQ5 mutant were detected by western blotting as
shown in Additional file 1: Figure 1.
Due to cyanobacterial cells containing multiple copies
of chromosomes [10], the complete replacement of wild
type alleles must be established and confirmed by PCR
(Figure 3 and 4). Primers used in this study were listed in
Additional file 1: Table 1. Because the whole inserted
fragment is too long to amplify from genomic DNA, the
over-expressed genes were checked by two reactions for
successful insertion and correct orientation of the
slr1609 or FAR gene and complete replacement of wild-
type alleles (Figure 3B and 4). The first reaction with the
primer (0168-2 or Pd1-3) of insert site and primer
(1609NdeI, 1609R or far-1) for the inserted gene verified
the genes were inserted in the correct orientation. The
second reaction with primers (0168-1/0168-2 or pD1-1/p
pD1-2d-2) of inserted site verified the wild-type was
Figure 1 The overall pathway of the fatty acid, fatty alcohol and fatty alkane in Synechocystis sp. PCC 6803. Dash arrow represents non-
native and heterologously introduced pathway. ACP, acyl carrier protein; AAR, acyl-ACP reductase; ADC, aldehyde decarbonylase; ACC, acetyl-
CoA carboxylase; FAS, fatty acid synthase; GPAT, glycerol-3-phosphate-acyl transferase; ACAT, acyl-CoA-ACP transferase; ACR, acyl-CoA reductase.
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replaced completely (Figure 3B and 4). The disrupted
genes were checked with internal primers (Figure 3A and
4B) or primers that flanked the insertion site to prove the
wild-type allele was replaced completely. The results of
the PCR indicated the correct mutants were constructed.
The amount of free fatty acids can be doubled in the
Synechocystis mutant strain with slr1609 knockout
The total free fatty acids of the wild-type strain and the
mutant strain GQ8 with slr1609 deletion were extracted
using the methods described in the Experimental Proce-
dures. The wild-type and the mutant strain displayed
similar growth behaviors (Figure 5A). However, the con-
tent of free fatty acids showed substantial differences
between two strains (Figure 5B). In the slr1609 deletion
mutant, the concentration of total free fatty acids was 6.7
± 0.2 μg/mL/OD, while that of the wild type was 3.5 ±
0.25 μg/mL/OD. The deletion of slr1609 increased free
fatty acid accumulation close to two folds. It indicates
that the dysfunction of fatty acid activation caused by the
deletion of slr1609 results in an increase of free fatty acid
accumulation.
As to the contents of the pool of free fatty acids, the
amount of unsaturated fatty acids with carbon chain
length of C16 and C18 was significantly higher in the
slr1609 knockout mutant strain compared to the wild-
type strain. Double bonds can only be introduced into
free fatty acid coupled to the glycerol backbone of mem-
brane lipids by acyl-lipid-type desaturases. Indicating that
unsaturated free fatty acids being released from mem-
brane lipids of senescent or damaged cells, while unsatu-
rated free fatty acids in AAS deletion mutant can not be
recycled and incorporated to membrane lipids.
In the mutant strain GQ3 with slr1609 over-expression,
there is no significant change to the production of free
fatty acids compared to the wild-type strain (data not
Figure 2 Maps of the plasmids (A) pGQ53, (B) pGQ11, (C) pGQ17 and (D) pGQ49.
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shown). It has been confirmed that free fatty acids are
released from membrane lipids in Synechocystis sp.
PCC6803 [10]. Indicating free fatty acid production is not
only determined by the fatty acyl-ACP pool size, but also
by the biosynthesis of membranes and hydrolysis of
membrane lipids which are physiologically regulated.
The production of alkanes was significantly reduced in
the slr1609 deletion mutant strain
Alkanes are the predominant constituents of gasoline,
diesel, and jet fuels. Production of alkanes has been
reported in a diversity of cyanobacteria, with heptade-
cane and heptadecene being the most abundant hydro-
carbons found in Synechocystis sp. PCC6803. In this
pathway fatty acyl-ACP is reduced to a fatty aldehyde by
a fatty acyl-ACP reductase (AAR) and then the fatty
aldehyde decarbonylase (ADC) is able to convert the
aldehyde into an alkane. Besides the fatty acyl-ACP pro-
duced by de novo fatty acid synthesis from acetyl-CoA,
acyl-ACP synthetase (AAS) is essential for recycling
fatty acids into fatty acyl-ACP. The results showed that
the production of hydrocarbons was significantly
reduced by around 90% in the mutant strain GQ8 with
an slr1609 deletion (0.047 ± 0.01 μg/mL/OD) compared
with the wild-type strain (0.38 ± 0.07 μg/mL/OD) (Fig-
ure 6B), and this indicates that AAS plays an essential
role in alkane biosynthesis. AAS can enhance the total
amount of fatty acyl-ACP available for alkane produc-
tion, and the acyl-ACP formed by AAS activity may be
more accessible to the acyl-ACP formed by de novo
fatty acid synthesis.
The production of alkanes was not enhanced by the
over-expressing slr1609 gene alone in the GQ3 strain
(0.39 ± 0.03 μg/mL/OD)(Figure 6B). Due to the activ-
ities of downstream enzymes of the alkane producing
pathway, AAR and ADC, are rather low and fatty acyl-
ACPs might not be efficiently converted to alkanes [11].
Fatty acyl-ACPs are also a supplier of fatty acyl groups
for biosynthesis of lipid A [12], phospholipids [13], and
membrane-derived lipo-polysaccharides [14].
Synechocystis AAS plays an important role in fatty alcohol
production
Fatty alcohols possess carbon chain length which range
from C8 to C22, and can be used as detergents, precur-
sors for synthesis of other chemicals or fuels. We have
constructed a fatty-alcohol-producing strain Syn-XT14,
by the introduction of a jojoba acyl-CoA reductase gene
into wide-type strain in previous work [4], and the effect
of Synechocystis AAS on fatty alcohol production were
examined by over-expressing (GQ5) or deleting the
slr1609 gene (GQ6) in Syn-XT14. The results showed
that fatty alcohol production was enhanced by about 60%
in GQ5 (19.8 ± 2.3 μg/L/OD) or decreased by about 60%
in GQ6 (4.9 ± 0.1 μg/L/OD) compared with Syn-XT14
(12.5 ± 2.0 μg/L/OD), respectively (Figure 7). The data
indicates that Synechocystis AAS plays an important role
in fatty alcohol production.
Figure 3 PCR analysis of the genotype of Synechocystis sp. PCC 6803 mutant strains. (A) lane 1: DNA marker (200 bp DNA Ladder
Marker), lane 2: genomic DNA of GQ8 was amplified by primers kus and kdas outside the inserted gene segment, lane 3: plasmid pGQ53 was
amplified by primers kvF and kvR located inside slr1609 gene (control), lane 4: genomic DNA of GQ8 was amplified by the same primers as lane
3, lane 5: genomic DNA of wild-type was amplified by the same primers as lane 3 (control). (B) lane1: DNA marker (1 kb DNA Ladder Marker),
lane2: genomic DNA of wild type was amplified by primers 0168-2 and 1609NdeI (control), lane3: genomic DNA of GQ3 was amplified by the
same primers as lane2, lane4: plasmid pGQ11 was amplified by the same primer as lane2 (control), lane5: genomic DNA of wild-type was
amplified by primers 0168-1 and 0168-2(control), lane6: genomic DNA of GQ3 was amplified by the same primers as lane5, lane7: H2O was used
as template, and the same primer as lane5 were used in PCR reaction(control).
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Although the native jojoba FAR has a preference for
very-long-chain acyl-CoA substrate (C20, C22 and C24),
assays of jojoba extracts indicated that it is capable of
reducing C16:0-ACP and C18:0-ACP [7]. It’s a reductase
with broad substrate specificity. It may be possible that
the acyl-ACP produced by AAS can also be accepted as
substrate in addition to acyl-CoA by jojoba FAR in engi-
neered Synechocystis strains. It is also possible that the
acyl-ACPs, which are synthesized by Synechocystis AAS,
could be in turn transacylated to acyl-CoAs by a reverse
catalysis of acetyl-CoA-ACP-transacylase (EC 2.3.1.38)
type reaction.
Conclusions
In this study the effects of fatty acid activation func-
tionalized by a fatty acyl-ACP synthase on the produc-
tion of fatty acid-based biofuels including fatty
alcohols and alkanes in a photosynthetic cyanobacter-
ium were evaluated and analyzed. We found fatty acid
activation to be essential for efficient production of
alkanes and plays a key role in manipulating fatty
alcohol production. The results here provide promis-
ing clues for metabolically engineering cyanobacteria
to improve photosynthetic production of fatty acid-
based biofuels.
Figure 4 PCR analysis of the genotype of Synechocystis sp. PCC 6803 mutant strains. (A) lane1: DNA marker (1 kb DNA Ladder Marker),
lane2: genomic DNA of wild-type was amplified by primers 0168-1 and far-1 (control), lane3: genomic DNA of GQ5 was amplified by the same
primers as lane2, lane4: plasmid pXT14 was amplified by the same primers as lane2, lane5: genomic of wild-type was amplified by primers
0168-1 and 0168-2, lane6: genomic DNA of GQ5 was amplified by the same primers as lane5, lane7: plasmid pXT14 was amplified by the same
primer as lane5 (control), lane8: genomic DNA of wild-type was amplified by primers pD1-3 and 1609R (control), lane9: genomic DNA of GQ5
was amplified by the same primers as lane8, lane10: plasmid pGQ49 was amplified by the same primers as lane8 (control), lane11: genomic
DNA of wild-type was amplified by primers pD1-3 and pD1-2d-2 (control), lane12: genomic DNA of GQ5 was amplified by the same primers as
lane11, lane13: plasmid pGQ49 was amplified by the same primers as lane11 (control). (B) lane1: DNA marker (1 kb DNA Ladder Marker), lane2:
genomic DNA of wild-type was amplified by the primers 0168-1 and far-1 (control), lane3: genomic DNA of GQ6 was amplified by the same
primers as lane2, lane4: plasmid pXT14 was amplified by the same primers as lane2 (control), lane5: genomic DNA of wild-type was amplified
by primers 0168-1 and 0168-2 (control), lane6: genomic DNA of GQ6 was amplified by the same primers as lane5, lane7: plasmid pXT14 was
amplified by the same primer as lane5 (control), lane8: genomic DNA of wild-type was amplified by primer 1609NdeI and 1609R (control, the
size of target DNA fragment should be 2091 bp), lane9: genomic DNA of GQ6 was amplified by the same primers as lane8 (the size of target
DNA fragment should be 1810 bp), lane10: plasmid pGQ17 was amplified by the same primers as lane8 (control, the size of target DNA
fragment should be 1810 bp).
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Methods
Chemicals and reagents
Pentadecanol, eicosane and nonadecanoic acid were
obtained from Sigma-Aldrich (USA). Other chemicals
were from Merck (Germany) or Ameresco (USA). Oligo
nucleotides and gene synthesis were carried out by Sangon
(Shanghai, China). Taq DNA polymerases and all restric-
tion endonucleases were from Fermentas (Canada) or
Takara (Japan). The DNA ladders were from Takara
(Japan). The kits used for molecular cloning were from
Omega (USA) or Takara (Japan).
Construction of Synechocystis sp. PCC683 mutant strains
All primers used in this study are listed in the Addi-
tional file 1.
The slr1609 gene was amplified from the genomic DNA
of Synechocystis sp. PCC6803 with the primers 1609NdeI/
1609R and subcloned into NdeI/XhoI site of the plasmid
pET21b (Novagen, USA) to generate the plasmid pGQ7.
The gene was cloned from pGQ7 with the primers
1609XbaI/1609DraI and subcloned into XbaI/SmaI site of
the plasmid pFQ20 [4] to generate the plasmid pGQ11.
The plasmid pXT68 was constructed based on the site
of psbA2 gene. Both upstream and downstream fragments
of psbA2 gene were cloned from the genomic DNA of
Synechocystis sp PCC6803 with the primers Pd1-2-f/Pd1-
2-r and pD1-2 d-1/pD1-2 d-2 respectively and inserted
into the TA cloning site of pMD18-T, to generate the
plasmids pXT25 and pXT59. The kanamycin resistance
(kanr) gene (ck2) cassette was excised with EcoRV and
XbaI from pRL446 [15] and inserted into the PstI site of
pXT25 with blunt ends, to generate the plasmid pXT62.
The 4.5 kb fragment containing ck2 and upstream of
psbA2 was excised with XbaI and SphI from pXT62 and
inserted into XbaI site of pXT59 with blunt ends, to gen-
erate the plasmid pXT68. Then, the slr1609 gene was
excised with NdeI and DraIII (blunted end) from pGQ7
Figure 5 Comparison of cell growth (A) and production of free
fatty acids (B) between Synechocystis sp. PCC 6803 wild-type
strain labeled as 6803yu and the mutant strain GQ8 with the
deletion of slr1609 gene.
Figure 6 Comparison of cell growth (A) and production of fatty
alkanes (B) in Synechocystis sp. PCC 6803 wild-type strain
labeled as 6803yu, the mutant strain GQ8 with the deletion of
slr1609 gene and GQ3 with the overexpression of slr1609 gene.
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and inserted into the NdeI/SalI (blunted end) site of
pXT68, to generate the plasmid pGQ49.
The plasmids pGQ17 and pGQ53 were constructed and
used to disrupt the slr1609 gene via homologous recombi-
nation in Synechocystis [16]. Genomic DNA was used as
the template to amplify the 500 bp N-terminal and
C-terminal fragments of slr1609 ORF using the primers
1609 kuF/R and 1609 kdF/R, respectively. The N-terminal
and C-terminal fragments were cloned into pMD18-T to
generate the plasmids pGQ12 and pGQ13, respectively.
The ck2 gene from pRL446 [15] was cloned into the
BamHI site of pGQ12 to generate plasmid pGQ14. After
digestion with DraI and EcoRI and blunting by T4 DNA
polymerase, the ck2 gene together with N-terminal frag-
ment of slr1609 from pGQ14 were cloned into the SmaI
site of plasmid pGQ13 to generate plasmid pGQ17. The
erythromycin resistance gene cce2 was digested with
EcoRV from pRL271 [17] and cloned into the blunted
BamHI site of pGQ17 to generate plasmid pGQ53.
Plasmids constructed and used in this study were listed in
Table 1.
All of the constructs were checked by enzyme diges-
tion and then transformed to Synechocystis sp. PCC6803
cells [18]. The plasmids pGQ11 and pGQ53 were trans-
formed to Synechocystis sp. PCC6803 wild-type to gen-
erate the mutant strains GQ3 and GQ8 respectively.
The plasmids pGQ17 and pGQ49 were transformed to
Synechocystis sp. PCC6803 mutant strain Syn-XT14 [4]
to generate two new mutant strains GQ6 and GQ5
respectively. For the initial selection of transformants,
the DNA/cell mixture was applied to BG11 agar plates.
After 18 h the membrane filters were applied to fresh
BG11 agar plates containing antibiotics (10 μg mL-1
spectinomycin, 10 μg mL-1 erythromycin or 5 μg mL-1/5
μg mL-1 spectinomycin/kanamycin). Homogeneous
mutants were obtained by successive streaking on BG11
plates containing antibiotics. Complete segregation of all
mutants was verified by employing PCR. Strains con-
structed and used in this study were listed in Table 2.
Cultivation of Synechocystis sp. PCC683 strains
Liquid cultures of Synechocystis sp. PCC 6803 were
grown photo-autotrophically in BG 11 media [19] at 30°
C under constant illumination at a photosynthetic
photon flux density of approximately 30 μmol photons
m-2 s-1 and with aeration by sterile air or in a shaker.
When necessary, the following antibiotics were added:
erythromycin (20 μg mL-1) and spectinomycin (20 μg
mL-1). Growth was monitored by following the OD at
730 nm. The Synechocystis sp. PCC6803 wild-type strain,
the mutant strains GQ8 with deletion of the slr1609
gene and GQ3 with overexpression of the slr1609 gene
were respectively grown in 100 mL Erlenmeyer flask
containing 50 mL of BG11 medium in a shaker for free
fatty acid analysis. The Synechocystis sp. PCC6803 wild-
type strain, the mutant strains Syn-XT14 with overex-
pression of the FAR gene, GQ6 with deletion of the
slr1609 gene and GQ5 with overexpression of the
slr1609 gene were respectively grown in a 500 mL
Erlenmeyer flask containing 300 mL of BG11 medium
with aeration by sterile air for fatty alkane or fatty alco-
hol analysis. The Synechocystis sp. PCC6803 wild-type
strain, the mutant strains GQ8 with deletion of the
slr1609 gene and GQ3 with overexpression of the
slr1609 gene were respectively grown in a 500 mL
Erlenmeyer flask containing 300 mL of BG11 medium
with aeration by sterile air for fatty alkane analysis.
Extraction and analysis of free fatty acids, fatty alkanes
and fatty alcohols
For extraction of free fatty acids, 20 mL of the culture
was lysed by sonication (total 30 min with 10 s on and
5 s off intervals) when the stationary phase (about 240
Figure 7 Comparison of cell growth (A) and production of fatty
alcohols (B) in engineered fatty alcohol-producing strain Syn-
XT14, GQ5 with the overexpression of slr1609 gene and GQ6
with the deletion of slr1609 gene.
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h) reached. To each 20 mL aliquot, 20 mL of 2:1 (v/v)
CHCl3:CH3OH were added and the resulting mixture
was mixed well [20]. For GC-MS analysis of free fatty
acids, 10 μg of nonadecanoic acid was added as the
internal standard. A two-phase system (top: aqueous,
bottom: organic) was generated after shaking for 1 h
and centrifugation at 3000 rpm at room temperature for
5 min. The bottom organic phase was collected and
concentrated under a stream of nitrogen at 55°C giving
a residue that was resuspended in 600 μL of hexane.
Aliquots of this mixture were analyzed by using GC-MS
with an Agilent 7890A-5975 C system equipped with
Agilent HP-INNOWax (30 m × 250 μm × 0.25 μm).
Helium (constant flow 1 mL/min) was used as the car-
rier gas. The temperature of the injector was 250°C and
the following temperature program was applied: 100°C
for 1 min, increase of 5°C min-1 to 200°C then increase
of 25°C min-1 to 240°C for 15 min.
Previous work in our lab showed that fatty alcohol
and alkane can not be detected in relative culture media
(data not shown). For extraction of fatty alkanes, Syne-
chocystis cells at stationary phase (about 240 h) were
harvested from 200 mL of culture by centrifugation.
The cells were resuspended in 10 mL of TE buffer
(pH8.0) and then lysed by sonication. The lysate added
with 30 μg of eciosane as internal standard was
extracted for 1 h at room temperature with 10 mL of
2:1 (v/v) CHCl3:CH3OH. The same following sample
preparation and GC-MS analysis methods described
above were used for fatty alkane analysis.
The same extraction methods described above for
fatty alkane analysis were used for fatty alcohol, except
adding 20 μg of 1-pentadecanol as the internal standard.
The following temperature program was applied here:
50°C for 1 min, increase of 20°C min-1 to 180°C then
increase of 10°C min-1 to 240°C for 20 min.
Additional material
Additional file 1: Figure 1. Western blot analysis of overexpressed AAS
protein in GQ3 and GQ5 mutant with anti-His-tag antibody. Table 1.
Primers used in this study.
Abbreviations
ACP: acyl carrier protein; AAR: acyl-ACP reductase; ADC: aldehyde
decarbonylase; FAR: fatty acyl-CoA reductase; ACS: acyl-CoA synthetase; AAS:
acyl-ACP synthetase; ACC: acetyl-CoA carboxylase; FAS: fatty acid synthase;
GPAT: glycerol-3-phosphate-acyl transferase; ACAT: acyl-CoA-ACP transferase;
ACR: acyl-CoA reductase.
Table 1 Plasmids constructed and used in this study
Plasmid Relevant characteristicsa, b Reference
pGQ7 Apr, pET21b derivative containing slr1609gene, T7 promoter This study
pXT25 Apr, pMD18-T derivative containing upstream fragment of psbA2, T7 promoter This study
pXT59 Apr, pMD18-T derivative containing downstream fragment of psbA2, T7 promoter This study
pXT62 Apr, Kanr, pMD18-T derivative containing upstream fragment of psbA2 and CK2 This study
pXT68 Apr, Kanr, pMD18-T derivative containing upstream and downstream fragments of psbA2, CK2 and sacB This study
pFQ20 Apr Sper, pKW1188SL derivative containing lacZ, Prbc promoter [4]
pGQ11 Apr Sper , pFQ20 derivative containing slr1609, Prbc promoter This study
pGQ49 Kanr, pXT68 derivative containing slr1609, PpsbA2 promoter This study
pGQ12 Apr, pMD18-T derivative containing upstream fragment of slr1609, T7 promoter This study
pGQ13 Apr, pMD18-T derivative containing downstream fragment of slr1609, T7 promoter This study
pGQ14 Apr, Kanr, pMD18-T derivative containing upstream fragment of slr1609 and CK2 This study
pGQ17 Apr, Kanr, pMD18-T derivative containing upstream and downstream fragments of slr1609 and CK2 This study
pGQ53 Apr, Cmr, Emr, pMD18-T derivative containing upstream and downstream fragments of slr1609, CCEII and sacB This study
pXT14 Sper, pFQ20 derivative containing FAR gene (jojoba), Prbc promoter [4]
a Ap, Ampicillin. Spe, Spectinomycin. Kan, kanamycin. Cm, Chloramphenicol. Em, Erythromycin.
bCK2 gene for kanamycin antibiotic resistance and CCEII gene for erythromycin antibiotic resistance.
Table 2 Strains constructed and used in this study
Strain Genotypea, Reference
6803yu Synechocystis sp. PCC6803 Wild-type, Glucose-
tolerance
Prof. Xu X.
GQ3 slr0168∷Omega Prbcslr1609 This study
GQ8 slr1609∷CCEII This study
GQ5 slr0168∷omega Prbc far (jojoba), psbA2∷CK2
PpsbA2slr1609
This study
GQ6 slr0168∷ omega Prbc far (jojoba); slr1609 ∷CK2 This study
Syn-
XT14
slr0168::Omega Prbc far (jojoba) Trbc [4]
a PpetE, 0.4 kb DNA fragment containing the promoter of petE gene. Prbc, 0.3
kb DNA fragment containing the promoter of rbc operon. Trbc, 0.2 kb DNA
fragment downstream of rbcS gene. PpsbA2, 1.5 kb DNA fragment containing
the promoter of psbA2 gene. All promoters and terminators mentioned here
are from Synechocystis sp. PCC 6803.
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